$LXRX Headlines GameStop shares drop on earnings, weak

New Post Public Reply Private Reply Replies (0) Message Board

Dec 6, 2014 at 9:42 AM

$LXRX Headlines

GameStop shares drop on earnings, weak outlook 6:27 p.m. Nov. 20, 2014 - Wallace Witkowski
Only these 10 stocks carry the highest ratings 5:16 a.m. Sept. 24, 2014 - Philip van Doorn
Lexicon Pharmaceuticals up 25% on drug trial 7:07 a.m. April 14, 2014 - MarketWatch
Merck's 20% work force reduction lifts shares; Walgreen stock climbs 11:19 a.m. Oct. 1, 2013 - Russ Britt
Synageva director bought shares for trust 1:41 p.m. Jan. 17, 2013 - Insider Monkey
Lexicon gets fast-track from FDA for IBS drug 1:16 p.m. Dec. 17, 2012 - MarketWatch.com
Lexicon prices offering at 10% discount 8:45 a.m. Oct. 18, 2012 - MarketWatch.com
Friday’s biggest gaining and declining stocks 3:48 p.m. Oct. 12, 2012 - Sue Chang
Lexicon: Progress with carcinoid syndrome drug 5:33 a.m. Oct. 12, 2012 - MarketWatch.com
Lexicon: progress with LX4211 for type 2 diabetes 5:46 a.m. June 25, 2012 - MarketWatch.com
How to trade penny stocks 2:57 p.m. Feb. 29, 2012 - Cody Willard
BioSante, Optimer boost drug stocks 3:05 p.m. May 31, 2011 - Val Brickates Kennedy
Thursday’s biggest gaining and declining stocks 4:45 p.m. Jan. 6, 2011 - Kate Gibson
Lexicon, Valeant, Amarin lead drug gainers 1:20 p.m. Jan. 6, 2011 - Val Brickates Kennedy
Drug indexes flat as Lexicon rockets on study 10:06 a.m. Jan. 6, 2011 - Val Brickates Kennedy
Tuesday's biggest winning and losing stocks 4:01 p.m. March 16, 2010 - MarketWatch
Sequenom stock drop leads biotech slide 3:22 p.m. March 16, 2010 - Wallace Witkowski
Monday's biggest gaining and declining stocks 4:51 p.m. March 8, 2010 - MarketWatch
Lexicon, Poniard weigh on drug stocks 1:40 p.m. March 8, 2010 - Val Brickates Kennedy
Lexicon Pharmaceuticals to sell $95 mln. in shares 6:37 a.m. March 8, 2010 - William L. Watts

InsiderInsights.com Daily Round Up 11/26/14: VRX, INTX, AEHR, HRG 12:53 a.m. Nov. 27, 2014 - Seeking Alpha
A Change In Strategy: Lexicon Pharmaceuticals 12:04 a.m. Nov. 24, 2014 - Seeking Alpha
Lexicon Pharmaceuticals Fights On 12:09 p.m. Nov. 21, 2014 - Seeking Alpha
10-Q: LEXICON PHARMACEUTICALS, INC./DE 4:23 p.m. Nov. 6, 2014 - Edgar Online - (EDG = 10Q, 10K)
Lexicon Pharmaceuticals' (LXRX) CEO Lonnel Coats on Q3 2014 Results - Earnings Call Transcript 1:35 a.m. Nov. 5, 2014 - Seeking Alpha
Lexicon Pharmaceuticals' (LXRX) CEO Lonnel Coats on Commercialization Agreement for Telotristat Etiprate with Ipsen for Ex-North America/Japan Licensing Conference (Transcript) 1:18 p.m. Oct. 22, 2014 - Seeking Alpha
Synergy Pharma presents plecanatide IBS-C clinical trial results 9:11 a.m. Oct. 21, 2014 - Seeking Alpha
Lexicon Pharmaceuticals (LXRX) Jumps: Stock Rises 15.7% - Tale of the Tape 7:51 a.m. Oct. 17, 2014 - Zacks.com
Thursday’s Top 10 After-Hours Stocks on the Move 3:59 p.m. Sept. 11, 2014 - 247WallSt.com
Lexicon Pharmaceuticals' CEO Presents at Morgan Stanley Healthcare Conference (Transcript) 3:09 p.m. Sept. 9, 2014 - Seeking Alpha
For Lexicon Pharmaceuticals, No News Remains Bad News 12:00 p.m. Aug. 11, 2014 - Seeking Alpha
Lexicon Pharmaceuticals' (LXRX) CEO Lonnel Coats on Q2 2014 Results - Earnings Call Transcript 12:55 a.m. Aug. 10, 2014 - Seeking Alpha
10-Q: LEXICON PHARMACEUTICALS, INC./DE 3:30 p.m. Aug. 7, 2014 - Edgar Online - (EDG = 10Q, 10K)
Notable earnings before Thursday’s open 4:30 p.m. Aug. 6, 2014 - Seeking Alpha
Lexicon (LXRX) Jumps: Stock Moves 7.6% Higher - Tale of the Tape 8:46 a.m. July 10, 2014 - Zacks.com
Lexicon (LXRX) Catches Eye: Stock Moves 13.0% Higher - Tale of the Tape 8:25 a.m. June 10, 2014 - Zacks.com
Lexicon Pharmaceuticals' (LXRX) Management Presents at 2014 Bank of America Merrill Lynch Healthcare Conference (Transcript) 6:10 p.m. May 13, 2014 - Seeking Alpha
Lexicon - Introducing A New Element In Diabetes Treatment, But A Difficult Road Ahead 2:25 p.m. May 13, 2014 - Seeking Alpha
10-Q: LEXICON PHARMACEUTICALS, INC./DE 4:01 p.m. May 8, 2014 - Edgar Online - (EDG = 10Q, 10K)
Lexicon Pharmaceuticals' (LXRX) CEO Dr. Arthur Sands on Q1 2014 Results - Earnings Call Transcript 2:57 p.m. May 8, 2014 - Seeking Alpha

Lexicon Announces Completion Of $280 Million In Financing Transactions 4:01 p.m. Nov. 26, 2014 - PR Newswire - PRF
Lexicon Announces Pricing Of Convertible Senior Notes Offering 1:00 a.m. Nov. 21, 2014 - PR Newswire - PRF
Lexicon Announces Pricing Of Common Stock Offering 1:00 a.m. Nov. 21, 2014 - PR Newswire - PRF
Lexicon Announces Proposed Convertible Senior Notes Offering 4:01 p.m. Nov. 19, 2014 - PR Newswire - PRF
Lexicon Announces Proposed Common Stock Offering 4:01 p.m. Nov. 19, 2014 - PR Newswire - PRF
Technical Updates on Biotech Stocks - ImmunoGen, Lexicon Pharma, ZIOPHARM Oncology, Arena Pharma, and Regulus Therapeutics 8:40 a.m. Nov. 19, 2014 - PR Newswire - PRF
Lexicon Strengthens Clincial Operations And Commercial Readiness 4:15 p.m. Nov. 4, 2014 - PR Newswire - PRF
Lexicon Pharmaceuticals Provides Clinical Pipeline Update And Reports 2014 Third Quarter Financial Results 4:05 p.m. Nov. 4, 2014 - PR Newswire - PRF
Lexicon To Report Third Quarter 2014 Financial Results On November 4, 2014 7:00 a.m. Nov. 3, 2014 - PR Newswire - PRF
BioSurplus To Hold Second Auction of Lab Equipment from Lexicon Pharmaceuticals 8:16 a.m. Oct. 23, 2014 - BusinessWire - BZX
Lexicon and Ipsen enter into ex-North America/Japan licensing and commercialization agreement for telotristat etiprate 12:01 a.m. Oct. 22, 2014 - PR Newswire - PRF
Analyst Scanner on Biotech Equities - Amgen, Exelixis, Regeneron Pharma, Lexicon Pharma, and BioMarin Pharma 8:00 a.m. Oct. 20, 2014 - PR Newswire - PRF
Lexicon Announces A Publication In The American Diabetes Association's Journal, Diabetes Care 3:30 p.m. Sept. 11, 2014 - PR Newswire - PRF
BioSurplus to Auction Lab Equipment from Lexicon Pharmaceuticals 7:11 a.m. Sept. 9, 2014 - BusinessWire - BZX
Lexicon To Present At The Morgan Stanley 2014 Global Healthcare Conference 6:00 a.m. Sept. 4, 2014 - PR Newswire - PRF
Health Care Sector Stocks on our Radar -- Pacific Biosciences of California, Thermo Fisher Scientific, Lexicon Pharma, Vical, and Jazz Pharma 7:50 a.m. Aug. 27, 2014 - PR Newswire - PRF
Lexicon To Present At The 2014 Wedbush Life Sciences Management Access Conference 7:00 a.m. Aug. 8, 2014 - PR Newswire - PRF
Lexicon Pharmaceuticals Provides Clinical Pipeline Update And Reports 2014 Second Quarter Financial Results 6:00 a.m. Aug. 7, 2014 - PR Newswire - PRF
Lexicon To Report Second Quarter 2014 Financial Results On August 7, 2014 6:00 a.m. Aug. 5, 2014 - PR Newswire - PRF
Equities to Watch in the Health Care Sector -- ImmunoCellular Therapeutics, Aeterna Zentaris, Lexicon Pharma, BioDelivery Sciences Intl., and Jazz Pharma 7:40 a.m. July 23, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

A.O. Smith Sells 81% of China Arm to CPE: Key Takeaways

When a major player like A.O. Smith decides to offload a piece of its business, folks tend to sit up and pay attention. This isn't just some run-of-the-mill shuffling. A.O. Smith has inked a deal with CPE to hand over an 81% stake in its China business. What does this transaction bring to the table and who stands to gain? Broken Down for the Curious Investor The numbers...

Ping An Shows Resilient Growth Amid Economic Pressure

Unpacking Ping An's Steady Climb Amid Tumult A few eyebrows might have raised when Ping An Insurance unveiled its nine-month report for 2026. Despite economic turbulence in China—courtesy of a gnarly global scene—the numbers were anything but rattled. Operating profit rose 8.3% year over year to a beefy RMB125,905 million. The equity pool swelled by 4.4% as of...

Socket Mobile Moves Listing from Nasdaq to OTCID

When Socket Mobile decided to jump ship from Nasdaq to the OTCID Market, they sure shook things up. We have a company that’s taking a bold leap, moving off the big-time Nasdaq stage to the less glitzy, but arguably more financially forgiving, floors of the OTC Markets. Why Leave Nasdaq? Cost-Cutting for Core Growth Now, above all else, the rationale screams ‘money...

Enertech's New Moves Aim to Make Geothermal Mainstream

Breaking Through Financial Barriers in Geothermal Energy Finally, we're seeing some real movement in the geothermal heat pump sector. The longtime hurdles that kept ground-sourced heating and cooling tech at arm's length from the everyday homeowner are starting to tumble, thanks to Enertech Global's latest initiatives. Enertech's Double Deal: A New Lease on Geothermal...

Eric Dalton: Redefining Homecare with Vision and Strategy

What's Behind Eric Dalton's Continued Recognition? Now, if you told me a healthcare leader’s named 'Visionary of the Year' twice in a row, my first thought isn't 'stretch goals' but 'show me the goods.' And that’s precisely what Eric J. Dalton has done. The Vice President at Angels on Call Homecare isn't just tooting his own horn; he's building a damn symphony in the...

Alchemy's Texas Move: Strategic Growth or Gamble?

Making a Splash in Texas IT Services Alchemy Technology Group's acquisition of Freeit Data Solutions isn't just another drop in the tech pond; it's a cannonball aimed at shaking up the IT and cybersecurity scenes in Texas. By bringing Freeit's impressive 16-year track record under its wing, Alchemy is flexing its muscles in a region already bustling with IT infrastructure...

Penske's Q3 2026: Revenue Up, Private Deal Awaits

Jumping straight into it, Penske Automotive Group (NYSE: PAG) just rolled out their quarterly numbers. The highlights? A 5% revenue bump, landing at $8.4 billion. That's nice, sure, but let's not get too cozy, there's a bigger elephant in this garage—it's the bold move to take the company private! Our old friend volatility still sends shivers down the spine of long-time...

McKinsey and Parloa Join Forces on AI Customer Service

AI-Revolutionizing Customer Service: The New Partnership Out of the boardroom and into the trenches, McKinsey joins hands with Parloa, aiming to reshape how enterprises handle customer service through artificial intelligence. Forget all the corporate fluff you've heard before; these guys are dead set on closing the massive gap companies face in deploying AI agents...

Shira Goodman Joins APEI Board: New Direction?

A New Chapter for American Public Education Alright, sit tight because this one’s got layers. American Public Education, Inc. (Nasdaq: APEI) just shook up its board by bringing in Shira Goodman, the former CEO of Staples. This move isn't just swapping one name for another; it’s about bolstering leadership at a time when strategic decisions are pivotal. Who is Shira...

Mercado González Opens, Integrates Mexican Culture

Dive into Mercado González's Cultural Opening Over in La Habra, Northgate González Market has just flung open the doors to its latest masterpiece: Mercado González. Picture this, a place where the mundanity of grocery shopping melds with a vibrant fiesta of Mexican cuisine, artisanry, and cultural vibes. They transformed an older store into something that commands not...